...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BJU international >Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry.
【24h】

Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry.

机译：用于局部晚期临床阶段T3前列腺癌的冷冻植物：来自Cryo-on-Line数据库（冷）注册表的报告。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cryoablation for patients with cT3 prostate cancer leads to less favourable bDFS than that after RP or RT for the same group of men. The after treatment rectourethral fistulisation rates for patients with cT3 disease are higher than in those with organ-confined prostate cancer treated with cryoablation; however, urinary dysfunction and sexual activity rates are similar for men with cT3 to those reported from this same registry in men with cT2 disease. The addition of neoadjuvant ADT (though not studied prospectively here) should be strongly considered if a patient with cT3 prostate cancer is to be treated with cryoablation.
机译：CT3前列腺癌的患者的冷冻植物导致相同组男性RP或RT后的BDF较低的BDF。 CT3疾病患者的患者治疗抗直碱瘘管率高于用冷冻剂处理的器官局限性前列腺癌; 然而，尿功能障碍和性活动率与CT3的男性相似，与CT2疾病的男性同一注册表报告的人。 如果患有CT3前列腺癌的患者是用冷冻诱导治疗的患者，应强烈地考虑Neoadjuvant ADT（虽然未经预期研究）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号